Lim Bryant David 4
4 · Prelude Therapeutics Inc · Filed Mar 2, 2023
Insider Transaction Report
Form 4
Lim Bryant David
CLO, CFO, Corp Sec.
Transactions
- Award
Employee Stock Option (Right to Buy)
2023-03-01+250,000→ 250,000 totalExercise: $5.93Exp: 2033-02-28→ Common Stock (250,000 underlying)
Footnotes (1)
- [F1]The stock option vests as to 25% of the total shares on March 1, 2024, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.